taurine has been researched along with Carcinoma, Hepatocellular in 14 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NorUDCA (24-norursodeoxycholic acid), the C₂₃-homolog of ursodeoxycholic acid (UDCA), showed remarkable therapeutic effects in cholestatic Mdr2 (Abcb4) (multidrug resistance protein 2/ATP-binding cassette b4) knockout mice with sclerosing/fibrosing cholangitis." | 7.76 | Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. ( Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R, 2010) |
| "Sorafenib (Sor) is a multi-kinase inhibitor." | 5.51 | Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects. ( Afifi, AM; El-Houseini, ME; El-Husseiny, AM; Khalil, MA; Tabashy, RH, 2019) |
| "The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often correlated with tumor progression and poorer clinical outcomes." | 5.48 | Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. ( Chen, CY; Cheng, ML; Chi, HC; Chung, IH; Huang, YH; Lin, KH; Lin, YH; Tsai, CY; Wu, MH; Yeh, CT, 2018) |
| "Increasing evidence suggests that taurine upregulated gene 1 (TUG1) is crucial for tumor progression; however, its role in hepatocellular carcinoma (HCC) and the underlying mechanisms are not well characterized." | 4.12 | Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis. ( Da, X; Fan, M; Huang, J; Li, Q; Lu, H; Lu, L; Mo, J, 2022) |
| "NorUDCA (24-norursodeoxycholic acid), the C₂₃-homolog of ursodeoxycholic acid (UDCA), showed remarkable therapeutic effects in cholestatic Mdr2 (Abcb4) (multidrug resistance protein 2/ATP-binding cassette b4) knockout mice with sclerosing/fibrosing cholangitis." | 3.76 | Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. ( Beuers, U; Denk, GU; Ferdinandusse, S; Fickert, P; Fuchsbichler, A; Hofmann, AF; Invernizzi, P; Kulik, W; Maitz, S; Rust, C; Trauner, M; Wimmer, R, 2010) |
| "Sorafenib (Sor) is a multi-kinase inhibitor." | 1.51 | Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects. ( Afifi, AM; El-Houseini, ME; El-Husseiny, AM; Khalil, MA; Tabashy, RH, 2019) |
| "The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often correlated with tumor progression and poorer clinical outcomes." | 1.48 | Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. ( Chen, CY; Cheng, ML; Chi, HC; Chung, IH; Huang, YH; Lin, KH; Lin, YH; Tsai, CY; Wu, MH; Yeh, CT, 2018) |
| "The treatment of alcohol dependence (AD) is a complex activity as the variables are numerous; however, those which must necessarily be taken into account are the type of AD, the internal comorbidities and the presence of any psychiatric comorbidity." | 1.43 | Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy. ( Borro, P; Leone, S; Testino, G, 2016) |
| "Whereas in both H4IIE rat hepatoma cells and primary hepatocytes TAUT mRNA levels were strongly dependent upon ambient osmolarity, mRNAs for other osmolyte transporters, i." | 1.30 | Osmoregulated taurine transport in H4IIE hepatoma cells and perfused rat liver. ( Häussinger, D; Warskulat, U; Wettstein, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, L | 1 |
| Huang, J | 1 |
| Mo, J | 1 |
| Da, X | 1 |
| Li, Q | 1 |
| Fan, M | 1 |
| Lu, H | 1 |
| Afifi, AM | 1 |
| El-Husseiny, AM | 1 |
| Tabashy, RH | 1 |
| Khalil, MA | 1 |
| El-Houseini, ME | 1 |
| Nabi, AA | 1 |
| Atta, SA | 1 |
| El-Ahwany, E | 1 |
| Elzayat, E | 1 |
| Saleh, H | 1 |
| Lin, YH | 1 |
| Wu, MH | 1 |
| Huang, YH | 1 |
| Yeh, CT | 1 |
| Cheng, ML | 1 |
| Chi, HC | 1 |
| Tsai, CY | 1 |
| Chung, IH | 1 |
| Chen, CY | 1 |
| Lin, KH | 1 |
| Borro, P | 1 |
| Leone, S | 1 |
| Testino, G | 1 |
| Yanagita, T | 1 |
| Han, SY | 1 |
| Hu, Y | 1 |
| Nagao, K | 1 |
| Kitajima, H | 1 |
| Murakami, S | 1 |
| Denk, GU | 1 |
| Maitz, S | 1 |
| Wimmer, R | 1 |
| Rust, C | 1 |
| Invernizzi, P | 1 |
| Ferdinandusse, S | 1 |
| Kulik, W | 1 |
| Fuchsbichler, A | 1 |
| Fickert, P | 1 |
| Trauner, M | 1 |
| Hofmann, AF | 1 |
| Beuers, U | 1 |
| Abd-Rabou, AA | 1 |
| Zoheir, KM | 1 |
| Ahmed, HH | 1 |
| Junankar, PR | 1 |
| Karjalainen, A | 1 |
| Kirk, K | 1 |
| Ito, T | 1 |
| Fujio, Y | 1 |
| Hirata, M | 1 |
| Takatani, T | 1 |
| Matsuda, T | 1 |
| Muraoka, S | 1 |
| Takahashi, K | 1 |
| Azuma, J | 1 |
| Park, SH | 2 |
| Lee, H | 2 |
| Park, KK | 2 |
| Kim, HW | 2 |
| Park, T | 2 |
| Lee, DH | 1 |
| Warskulat, U | 1 |
| Wettstein, M | 1 |
| Häussinger, D | 1 |
| Wördemann, M | 1 |
| Fandrey, J | 1 |
| Jelkmann, W | 1 |
14 other studies available for taurine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.
Topics: Animals; Cancer-Associated Fibroblasts; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; | 2022 |
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.
Topics: Carcinoma, Hepatocellular; Cell Proliferation; Cytokines; Drug Therapy, Combination; Forkhead Transc | 2019 |
Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma.
Topics: Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationshi | 2021 |
Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
Topics: Biopsy, Needle; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Gene Expression Regulation, Neo | 2018 |
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug C | 2016 |
Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells.
Topics: Apolipoprotein B-100; Carcinoma, Hepatocellular; Cholesterol; Cholesterol Esters; Humans; Lipid Meta | 2008 |
Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Carcinoma, Hepatocellular; Cholangitis; Cholestasis; | 2010 |
Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; CD4 Antigens; CD8 Antigens; Cell Line, Tumor; Cell | 2012 |
Osmotic swelling activates two pathways for K+ efflux in a rat hepatoma cell line.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Liver Neoplasms; Osmolar Concentration; Osmosi | 2004 |
Expression of taurine transporter is regulated through the TonE (tonicity-responsive element)/TonEBP (TonE-binding protein) pathway and contributes to cytoprotection in HepG2 cells.
Topics: Animals; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA, Neoplasm; Gene Expression | 2004 |
Taurine-responsive genes related to signal transduction as identified by cDNA microarray analyses of HepG2 cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression; Gene Expression Profiling; Humans; Int | 2006 |
Taurine-induced changes in transcription profiling of metabolism-related genes in human hepatoma cells HepG2.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Energy Metabolism; Gene Expression Profiling; | 2006 |
Osmoregulated taurine transport in H4IIE hepatoma cells and perfused rat liver.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Betaine; Biological Transport; Blotting, | 1997 |
Tumor necrosis factor-alpha production by human hepatoma cell lines is resistant to drugs that are inhibitory to macrophages.
Topics: Adjuvants, Immunologic; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance, Neoplasm; Humans; | 1998 |